MLTX (MoonLake Immunotherapeutics) Stock Market Reviews

crown

search

Read and share opinions on MLTX (MoonLake Immunotherapeutics) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

MLTX

MoonLake Immunotherapeutics

clarify Biotechnology

bookmark Healthcare

public Switzerland

Sell Neutral Buy

Latest News

MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
Nov 5, 2025
Chief Financial Officer of MoonLake Immunotherapeutics Matthias Bodenstedt Buys 1.8% More Shares
Oct 11, 2025
MoonLake Immunotherapeutics (MLTX): Assessing Valuation Following Phase 3 Trial Miss and Legal Scrutiny
Oct 4, 2025
Top Midday Decliners
Sep 29, 2025
Applovin, furniture stocks, MoonLake: Trending Tickers
Sep 29, 2025
MoonLake's SLK Showed Limited Effectivesness in Recent Trials, Impacting Sales, Commercial Outlook, RBC Says
Sep 29, 2025
MoonLake Immunotherapeutics' Skin Disease Drug Hits Key Goals in Phase 3 Trials, Lags Behind UCB Rival
Sep 29, 2025
MoonLake Immunotherapeutics (MLTX) Q2 Net Loss Widens to US$55 Million
Sep 13, 2025
Leerink Partners Reiterated a Buy on MoonLake Immunotherapeutics (MLTX)
Sep 10, 2025
MoonLake Immunotherapeutics (MLTX): A Bull Case Theory
Aug 17, 2025

Reviews